Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study

CONCLUSION: The safety and efficacy of multiagent chemotherapy in patients aged 75 years or over were similar to those in younger patients. Modern multiagent regimens could be a safe and viable treatment option for clinically fit patients aged at least 75 years.PMID:34155509 | DOI:10.1093/bjs/znab092

Source: The British Journal of Surgery - June 22, 2021 Category: Surgery Authors: A Oba Y H A Wu C H Lieu C Meguid K L Colborn L Beaty M H Al-Musawi S L Davis A D Leal T Purcell G King E S Wooten Y Fujiwara K A Goodman T Schefter S D Karam A L Gleisner S Ahrendt S Leong W A Messersmith R D Schulick M Del Chiaro Source Type: research